These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 11176392)

  • 21. The impact of treatment choice for localized prostate cancer on response to phosphodiesterase inhibitors.
    Lee IH; Sadetsky N; Carroll PR; Sandler HM
    J Urol; 2008 Mar; 179(3):1072-6; discussion 1076. PubMed ID: 18206926
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prostate cancer and its effect on sexuality.
    Billington A
    Community Nurse; 1998 Nov; 4(10):33-4. PubMed ID: 10326380
    [No Abstract]   [Full Text] [Related]  

  • 23. Erectile function after brachytherapy with external beam radiation for prostate cancer.
    Fujioka H; Ishimura T; Sakai Y; Fujii T; Jo Y; Takenaka A; Fujisawa M
    Arch Androl; 2004; 50(4):295-301. PubMed ID: 15277008
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of the impact of androgen deprivation therapy on sildenafil citrate response following radiation therapy for prostate cancer.
    Teloken PE; Ohebshalom M; Mohideen N; Mulhall JP
    J Urol; 2007 Dec; 178(6):2521-5. PubMed ID: 17937948
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A prospective longitudinal study comparing a radical retropubic prostatectomy and permanent prostate brachytherapy regarding the health-related quality of life for localized prostate cancer.
    Hashine K; Kusuhara Y; Miura N; Shirato A; Sumiyoshi Y; Kataoka M
    Jpn J Clin Oncol; 2008 Jul; 38(7):480-5. PubMed ID: 18621847
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Erectile function durability following permanent prostate brachytherapy.
    Taira AV; Merrick GS; Galbreath RW; Butler WM; Wallner KE; Kurko BS; Anderson R; Lief JH
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(3):639-48. PubMed ID: 19303721
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect on erectile function of 103palladium implantation for localized prostate cancer.
    Ponholzer A; Oismüller R; Somay C; Büchler F; Maier U; Hawliczek R; Rauchenwald M; Madersbacher S
    BJU Int; 2005 Apr; 95(6):847-50. PubMed ID: 15794796
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in continence and erectile function between 2 and 4 years after radical prostatectomy.
    Glickman L; Godoy G; Lepor H
    J Urol; 2009 Feb; 181(2):731-5. PubMed ID: 19091349
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sexual function after permanent 125I-brachytherapy for prostate cancer.
    Mabjeesh N; Chen J; Beri A; Stenger A; Matzkin H
    Int J Impot Res; 2005; 17(1):96-101. PubMed ID: 15510186
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preserving potency after prostate cancer surgery.
    Harv Mens Health Watch; 2002 Sep; 7(2):7-8. PubMed ID: 12356553
    [No Abstract]   [Full Text] [Related]  

  • 31. Prostate cancer: wait or treat? How to apply new findings to your individual situation.
    Thompson IM
    Health News; 2002 Nov; 8(11):5. PubMed ID: 12523249
    [No Abstract]   [Full Text] [Related]  

  • 32. Editorial comment on: Oncological and functional results of antegrade radical retropubic prostatectomy for the treatment of clinically localised prostate cancer.
    van der Poel HG
    Eur Urol; 2008 Mar; 53(3):561-2. PubMed ID: 17683855
    [No Abstract]   [Full Text] [Related]  

  • 33. Assessment of patient concern and adequacy of informed consent regarding infertility resulting from prostate cancer treatment.
    Boyd BG; McCallum SW; Lewis RW; Terris MK
    Urology; 2006 Oct; 68(4):840-4. PubMed ID: 17070364
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improving cancer control and recovery of potency after radical prostatectomy: nerve sparing versus nerve resection with grafting.
    Cozzi P
    ANZ J Surg; 2008 Oct; 78(10):834-5. PubMed ID: 18959630
    [No Abstract]   [Full Text] [Related]  

  • 35. Estimating the risk of long-term erectile, urinary and bowel symptoms resulting from prostate cancer treatment.
    Bhatnagar V; Stewart ST; Huynh V; Jorgensen G; Kaplan RM
    Prostate Cancer Prostatic Dis; 2006; 9(2):136-46. PubMed ID: 16402091
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preferences for sexual information resources in patients treated for early-stage prostate cancer with either radical prostatectomy or brachytherapy.
    Davison BJ; Keyes M; Elliott S; Berkowitz J; Goldenberg SL
    BJU Int; 2004 May; 93(7):965-9. PubMed ID: 15142144
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The psychosocial aspects of sexual recovery after prostate cancer treatment.
    Wittmann D; Northouse L; Foley S; Gilbert S; Wood DP; Balon R; Montie JE
    Int J Impot Res; 2009; 21(2):99-106. PubMed ID: 19158798
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Erectile dysfunction after radiotherapy for prostate cancer.
    Mendenhall WM; Henderson RH; Indelicato DJ; Keole SR; Mendenhall NP
    Am J Clin Oncol; 2009 Aug; 32(4):443-7. PubMed ID: 19657239
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Time course and predictors of symptoms after primary prostate cancer therapy.
    Talcott JA; Manola J; Clark JA; Kaplan I; Beard CJ; Mitchell SP; Chen RC; O'Leary MP; Kantoff PW; D'Amico AV
    J Clin Oncol; 2003 Nov; 21(21):3979-86. PubMed ID: 14581420
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in continence and health-related quality of life after curative treatment and watchful waiting of prostate cancer.
    Katz G; Rodriguez R
    Urology; 2007 Jun; 69(6):1157-60. PubMed ID: 17572206
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.